Topiramate
NDC 27241-300, Topiramate, capsule, extended release, from Ajanta Pharma USA Inc..
- Product NDC
- 27241-300
- Status
- Listed
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219564
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27241-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE200 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27241-300-30 | 27241030030 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (27241-300-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/813f5fe2-df82-479c-8014-d503ff5df52b
Use it
Look up 27241-300 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27241-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27241-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.